Stanley Druckenmiller, whose net worth is around $6.9 billion, made most of his fortune as a hedge fund manager, and became a well-known name on Wall Street while working for George Soros until 2000.
His investment firm, Duquesne Family Office, is one of the more closely watched family offices, with over $3.7 billion in assets under management. Given its track record of success, it has become carefully followed by some investors looking for inspiration.
The firm currently has a stake in 78 companies, with the top five holdings accounting for over 38%. Below are those key holdings and how much of the portfolio each makes up:
| Company | Duquesne Portfolio Allocation |
|---|---|
| Natera (NTRA 1.51%) | 15.17% |
| Coherent (COHR +0.74%) | 7.18% |
| Woodward (WWD 1.43%) | 5.48% |
| Teva Pharmaceutical (TEVA 2.65%) | 5.33% |
| Coupang (CPNG 0.46%) | 5.26% |
Source: Duquesne Family Office 13F filing for Q4 2024. Allocations as of Dec. 31, 2024.
One noticeable change in the list of top holdings was that Teva Pharmaceutical replaced Seagate Technology in the top five as the firm sold off shares in the latter.
The success of the Duquesne Family Office's top holdings
It has been a good run for the firm's top five holdings since the start of 2024: Each noticeably outperformed the stock market's three main indexes: the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average.
The firm's top holdings are companies in the healthcare, technology, industrial, and consumer discretionary sectors, which makes sense considering those are, for the most part, the portfolio's most-represented sectors (industrials being the exception).
It will be interesting to see what moves the firm makes this year, as the broader stock market has stumbled thus far in 2025. Duquesne is no stranger to changing its holdings -- its portfolio averages a 45% turnover rate -- so you can bet Druckenmiller will act to take advantage of potential market opportunities.
